Trophoblast Development and Stem Cell Differentiation

Trophoblasts are the defining epithelial cells of the placenta, arising from the trophectoderm of the early embryo and responsible for establishment of the maternal–fetal interface. Their lineage bifurcates into villous cytotrophoblasts, which provide a proliferative stem‐like pool, and differentiated subtypes including the multinucleated syncytiotrophoblast that mediates nutrient exchange, and invasive extravillous trophoblasts that remodel maternal arteries. Over the past decade, the derivation of self‐renewing human trophoblast stem cells (hTSCs) and the development of three‐dimensional organoid and reprogramming systems have transformed our ability to model human placentation. Key signalling pathways—such as WNT, BMP and Notch—and transcription factors including GATA3, TEAD4 and TFAP2C coordinate the balance between stemness and differentiation. Advances in single‐cell transcriptomics and chromatin profiling have begun to resolve the dynamic gene regulatory networks that underlie the emergence of specialised trophoblast phenotypes. Translational applications span from improved understanding of preeclampsia and intrauterine growth restriction to the design of in vitro placenta models for drug screening and toxicology.

Research from Nature Portfolio

Recent studies have demonstrated that stable human induced trophoblast stem cells can be generated directly from fibroblasts without passing through a pluripotent state. A defined set of transcription factors (GATA3, OCT4, KLF4 and MYC) was shown to establish a bona fide trophoblast stem‐cell state by targeting trophoblast‐specific loci, inducing a chromatin opening landscape distinct from the one generated via pluripotency factors. Time-course transcriptome and chromatin assays revealed that these cells faithfully activate a core trophoblast programme and exhibit self-renewal and differentiation potential akin to embryonically derived hTSCs, even in the absence of canonical pluripotency genes. This work provides a robust platform for generating patient-specific trophoblast models and underscores the dispensability of pluripotency in trophoblast lineage acquisition.

Trophoblast Development and Stem Cell Differentiation publication trend

The graph below shows the total number of articles in trophoblast development and stem cell differentiation across all publications each year (not limited to Nature Index journals).

Technical terms

Trophoblast: The epithelial cells forming the outer layer of the blastocyst that differentiate into specialised placental subtypes.

Human trophoblast stem cell (hTSC): A self-renewing cell population capable of giving rise to villous and extravillous trophoblast lineages in vitro.

Super-enhancer: A cluster of enhancers with exceptionally high transcription factor occupancy and chromatin activity, driving cell identity genes.

Organoid: A three-dimensional multicellular structure derived from stem cells that mimics key aspects of tissue architecture and function.

Pluripotency: The ability of a stem cell to differentiate into all somatic lineages of the embryo but not extraembryonic trophoblast.

Chromatin accessibility: The state of chromatin that permits transcription factor binding and gene expression, often assessed by nuclease sensitivity or histone modification mapping.

References

1. Pluripotency-independent induction of human trophoblast stem cells from fibroblasts. Nature Communications (2023).
2. Super-enhancer-associated transcription factors collaboratively regulate trophoblast-active gene expression programs in human trophoblast stem cells. Nucleic Acids Research (2023).
3. Generating Functional Multicellular Organoids from Human Placenta Villi. Advanced Science (2023).
4. Human placenta and trophoblast development: key molecular mechanisms and model systems. Cellular and Molecular Life Sciences (2019).